Moleculin Biotech, Inc. (MBRX) earnings
Quarterly results of Moleculin Biotech, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Moleculin Biotech, Inc. was expected to report around October 27, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Moleculin Biotech, Inc. reported revenue of $0 and a net loss of $7.6M.
Diluted earnings per share were -$1.40.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $0 | - | -$7.6M | -$1.40 |
| Q1 FY2026 | $0 | - | -$12.8M | -$3.54 |
| Q4 FY2025 | $0 | - | $15.6M | - |
| Q3 FY2025 | $0 | - | -$25.4M | -$17.05 |
| Q2 FY2025 | $0 | - | -$17.8M | -$28.70 |
| Q1 FY2025 | $0 | - | -$5.9M | -$15.81 |
| Q4 FY2024 | $0 | - | -$6.6M | - |
| Q3 FY2024 | $0 | - | -$7M | -$47.44 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
When is Moleculin Biotech, Inc.'s next earnings date?
Moleculin Biotech, Inc. was expected to report around October 27, 2026; nothing is on file with the SEC yet.
What were Moleculin Biotech, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Moleculin Biotech, Inc. reported revenue of $0 and a net loss of $7.6M. The figures come from its filing with the SEC.
Get an email when MBRX reports
Follow MBRX and we email you its next results the day they are filed, with the numbers explained.